-
-
-
-
-
-
-
AMAG Pharmaceuticals Prices Public Offering of $175 Million of Common Stock
-
-
-
-
-
-
-
Baird Reiterates an 'Outperform' on AMAG Pharmaceuticals (AMAG); Three Key Reasons to Remain Positive Including Takeout
-
-
-
-
-
-
-
Baird Downgrades AMAG Pharmaceuticals (AMAG) to Neutral
-
-
-
-
-
-
28,054 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

